These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3906941)

  • 1. Anti-endotoxin in the treatment of severe surgical septic shock. Results of a randomized double-blind trial.
    Aitchison JM; Arbuckle DD
    S Afr Med J; 1985 Nov; 68(11):787-9. PubMed ID: 3906941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemofiltrastion does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T; Briegel J; Schelling G; Jochum M
    Eur J Med Res; 2005 Jan; 10(1):11-7. PubMed ID: 15737948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemofiltration does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T; Briegel J; Schelling G; Jochum M
    Eur J Med Res; 2005 Feb; 10(2):81-7. PubMed ID: 15817428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
    Stephens DP; Thomas JH; Higgins A; Bailey M; Anstey NM; Currie BJ; Cheng AC
    Crit Care Med; 2008 Feb; 36(2):448-54. PubMed ID: 18216600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary study on treatment of septic shock patients with antilipopolysaccharide IgG from blood donors.
    Fomsgaard A; Baek L; Fomsgaard JS; Engquist A
    Scand J Infect Dis; 1989; 21(6):697-708. PubMed ID: 2617211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
    Ziegler EJ; Fisher CJ; Sprung CL; Straube RC; Sadoff JC; Foulke GE; Wortel CH; Fink MP; Dellinger RP; Teng NN
    N Engl J Med; 1991 Feb; 324(7):429-36. PubMed ID: 1988827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior mesenteric artery occlusion shock in cats: modification of the endotoxemia by antilipopolysaccharide antibodies (anti-LPS).
    Gathiram P; Gaffin SL; Wells MT; Brock-Utne JG
    Circ Shock; 1986; 19(2):231-7. PubMed ID: 3719923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
    Jacobs S; Price Evans DA; Tariq M; Al Omar NF
    Crit Care Med; 2003 Jul; 31(7):1938-46. PubMed ID: 12847386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibodies to lipoid A in the treatment of septic shock].
    Jaspers L; Marget W; Mar PJ; Hoffmann K; Langecker P; Ruckdeschel G; Obermeier A; Kastenbauer E
    Infection; 1987; 15(2):146-52. PubMed ID: 3298069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial.
    Boerma EC; Koopmans M; Konijn A; Kaiferova K; Bakker AJ; van Roon EN; Buter H; Bruins N; Egbers PH; Gerritsen RT; Koetsier PM; Kingma WP; Kuiper MA; Ince C
    Crit Care Med; 2010 Jan; 38(1):93-100. PubMed ID: 19730258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-lipopolysaccharide immunotherapy in management of septic shock of obstetric and gynaecological origin.
    Lachman E; Pitsoe SB; Gaffin SL
    Lancet; 1984 May; 1(8384):981-3. PubMed ID: 6143965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the effect of fluid resuscitation as guided either by lactate clearance rate or by central venous oxygen saturation in patients with sepsis].
    Yu B; Tian HY; Hu ZJ; Zhao C; Liu LX; Zhang Y; Zhu GJ; Wang LT; Wu XH; Li J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Oct; 25(10):578-83. PubMed ID: 24119693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of antilipopolysaccharide (anti-LPS) antibodies in the management of septic shock. A preliminary report.
    Gaffin SL; Lachman E
    S Afr Med J; 1984 Feb; 65(5):158-61. PubMed ID: 6695272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness.
    Granja C; Dias C; Costa-Pereira A; Sarmento A
    Crit Care; 2004 Apr; 8(2):R91-8. PubMed ID: 15025783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group.
    Derkx B; Wittes J; McCloskey R
    Clin Infect Dis; 1999 Apr; 28(4):770-7. PubMed ID: 10825037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock.
    Pontes-Arruda A; Aragão AM; Albuquerque JD
    Crit Care Med; 2006 Sep; 34(9):2325-33. PubMed ID: 16850002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.
    Ziegler EJ; McCutchan JA; Fierer J; Glauser MP; Sadoff JC; Douglas H; Braude AI
    N Engl J Med; 1982 Nov; 307(20):1225-30. PubMed ID: 6752708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.
    Bone RC; Fisher CJ; Clemmer TP; Slotman GJ; Metz CA; Balk RA
    N Engl J Med; 1987 Sep; 317(11):653-8. PubMed ID: 3306374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin Removal in Septic Shock with the Alteco LPS Adsorber Was Safe But Showed no Benefit Compared to Placebo in the Double-Blind Randomized Controlled Trial-the Asset Study.
    Lipcsey M; Tenhunen J; Pischke SE; Kuitunen A; Flaatten H; De Geer L; Sjölin J; Frithiof R; Chew MS; Bendel S; Kawati R; Larsson A; Mollnes TE; Tønnessen TI; Rubertsson S
    Shock; 2020 Aug; 54(2):224-231. PubMed ID: 31880758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.